510(k) device
K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093C
Kamiya Biomedical Co. · Ige, Antigen, Antiserum, Control (DGC, Class II) · First FDA decision Dec 10, 2004, newest Dec 10, 2004Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
6
Naming "K-Assay"
MAUDE reports
0
Brand "K-Assay", since 2015
PubMed studies
36
Mentioning "K-Assay"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093C
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K042241 · Decided Dec 10, 2004 · 113 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "K-Assay", any status and sponsor, newest update first.
Istituto Oncologico Veneto IRCCSAcademic, hospital or other
NCT07948200 · 60 participants (planned) · Start Jan 31, 2027 · Primary completion Jan 31, 2029
Device: Bladder EpiCheck · For: Non-Muscle-Invasive Bladder Cancer
Sites: Padova, Italy
- Lucid Registry StudyRecruiting
Lucid Diagnostics, Inc.Not on our public-company list
NCT05965999 · 8,000 participants (planned) · Start Apr 11, 2023 · Primary completion Dec 31, 2027
Device: EsoCheck® · For: Barrett Esophagus; Esophageal Adenocarcinoma; Barretts Esophagus With Dysplasia and 1 more
Sites: Lake Forest, California
- Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid TestNot yet recruiting
CorDx, Inc.Not on our public-company list
NCT07430410 · 200 participants (planned) · Start Feb 12, 2026 · Primary completion Dec 12, 2026
Device: CorDx Tyfast Flu A/B & COVID-19 At-Home Multiplex Rapid Test · For: SARS-CoV-2 Infection; Influenza A; Influenza B
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "K-Assay", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DGC
6 reports: 6 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "K-Assay"[tiab]. The summary above synthesizes these.
- Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy.
Fan G, Li X, Li F, et al. · Phytomedicine · 2025
- Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials.
de Vera A, Clemens PR, Dang UJ, et al. · Steroids · 2025Randomized Controlled Trial, Clinical Trial, Phase I
- Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in Drosophila.
Arsac JN, Sedru M, Dartiguelongue M, et al. · Int J Mol Sci · 2021
- Assessment of Variability in the SOMAscan Assay.
Candia J, Cheung F, Kotliarov Y, et al. · Sci Rep · 2017Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural
- Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion.
Moon SP, Balana AT, Galesic A, et al. · J Org Chem · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination.
Pischedda S, O'Connor D, Fairfax BP, et al. · Clin Epigenetics · 2021Research Support, Non-U.S. Gov't
- A label-free fluorescence assay for potassium ions using riboflavin as a G-quadruplex ligand.
Xu L, Sun N, Zhou L, et al. · Analyst · 2015Research Support, Non-U.S. Gov't
- Superior fluorescent probe for detection of potassium ion.
Chen Z, Tan L, Hu L, et al. · Talanta · 2015Research Support, Non-U.S. Gov't
- Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods.
McConnell JP, Branum EL, Ballman KV, et al. · Clin Chem Lab Med · 2002Comparative Study
- DNA Methylation and SNPs in VCX are Correlated with Sex Differences in the Response to Chronic Hepatitis B.
Hu XQ, Zhou Y, Chen J, et al. · Virol Sin · 2019
- Mechanistic basis for LQT1 caused by S3 mutations in the KCNQ1 subunit of IKs.
Eldstrom J, Xu H, Werry D, et al. · J Gen Physiol · 2010Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Genome-wide association study identifies a major gene for beech bark disease resistance in American beech (Fagus grandifolia Ehrh.).
jalik I, Koch J, Carey D, et al. · BMC Genomics · 2017Research Support, U.S. Gov't, Non-P.H.S.
Other devices of this type
Also filed under product code DGC.
- Quantia IgEBiokit, S.A. · 510(k) 2023
- ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control StripPhadia AB · 510(k) 2016
- Kenota 1 Total IgEKenota, Inc. · 510(k) 2024
- Total Immunoglobulin E (IgE)Beckman Coulter, Inc. · 510(k) 2022
- ADVIA Centaur Total IgE (tIgE)Siemens Healthcare Diagnostics, Inc. · 510(k) 2020
- Dimension Vista Ige Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- LacrytestAdiatec SA · 510(k) 2004
- Immunetech Total Ige SystemImmunetech Corporation · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.